MK

Mahitha Kodali

Active Director Director DIN 10109746
DIN 10109746 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Mahitha Kodali

Data last updated:

Mahitha Kodali is a Director at Celestum Biotech Private Limited (since 2023). Celestum Biotech Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 10109746
Primary Designation Director
First Appointment 10 Apr 2023
Oldest Company Age 3 yrs
Largest company Celestum Biotech Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Celestum Biotech Private Limited U01619PN2023PTC219391
Director10 Apr 20232023₹12.5 Lakh (FY 2025)Active

Board colleagues of Mahitha Kodali

NameDINCompanyDesignation
Mukkala Keerthi Sai11379377Celestum Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Celestum Biotech Private Limited
Premium access

Shareholding and investment profile for Mahitha Kodali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahitha Kodali

Mahitha Kodali currently holds 1 directorship: Celestum Biotech Private Limited (Director, since 10 Apr 2023, revenue ₹12.5 Lakh (FY 2025)).

Mahitha Kodali was first appointed on 10 Apr 2023 as Director at Celestum Biotech Private Limited.

The current boards of Mahitha Kodali's companies include Mukkala Keerthi Sai (Celestum Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available